Related Experiment Video
Updated: Aug 29, 2025

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
CHD4 mediates SOX2 transcription through TRPS1 in luminal breast cancer
Jun Zhang1, Xiang Lv1, Bo Wei1
1Department of Biochemistry, School of Life Sciences, Nanjing Normal University, Nanjing, China.
Abstract:
Chromodomain helicase DNA binding protein 4 (CHD4), as a core component of the nucleosome remodeling and deactetylase (NuRD) complex, participated in the inititation and development of myriad cancers. However, little is known about the linkage between CHD4 and breast cancer stemness. Here, we found that CHD4 repress the expression of SOX2, a key regulator of cancer stem cells (CSCs), to suppress cancer stemness in breast cancer. Mechanistically, CHD4 binds to the promoter of SOX2 depend on TRPS1. And CHD4 transcriptional activation of SOX2 was abolished by TRPS1. These findings identify CHD4 as a regulator of SOX2 linked to breast cancer stemness and provide detailed mechanistic of CHD4 in CSC functions.
Insights
Chromodomain helicase DNA binding protein 4 (CHD4) suppresses breast cancer stemness by repressing SOX2 expression. This regulation is mediated by CHD4 binding to the SOX2 promoter, influenced by TRPS1.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Chromodomain helicase DNA binding protein 4 (CHD4) is implicated in various cancers.
- The role of CHD4 in breast cancer stemness remains largely unexplored.
- Cancer stem cells (CSCs) drive tumor initiation and progression.
Purpose of the Study:
- To investigate the role of CHD4 in regulating breast cancer stemness.
- To elucidate the molecular mechanisms linking CHD4 to SOX2, a key CSC regulator.
Main Methods:
- Analysis of CHD4's effect on SOX2 expression in breast cancer.
- Chromatin immunoprecipitation (ChIP) assays to determine CHD4 binding to the SOX2 promoter.
- Investigating the role of TRPS1 in mediating CHD4-SOX2 interaction.
Main Results:
- CHD4 was found to repress SOX2 expression, thereby suppressing cancer stemness in breast cancer.
- CHD4 directly binds to the promoter region of SOX2.
- TRPS1 is essential for CHD4's transcriptional repression of SOX2.
Conclusions:
- CHD4 acts as a suppressor of breast cancer stemness through the repression of SOX2.
- The findings reveal a novel mechanism involving CHD4, TRPS1, and SOX2 in controlling CSC functions.
- CHD4 is identified as a potential therapeutic target for overcoming breast cancer stemness.
Related Concept Videos
Master Transcription Regulators
Hedgehog Signaling Pathway
Inheritance of Chromatin Structures
Pleiotropy
Co-activators and Co-repressors
TGF - β Signaling Pathway

